Stocks and Investing Stocks and Investing
Mon, December 20, 2021

Edwin Zhang Maintained (CALT) at Strong Buy with Increased Target to $62 on, Dec 20th, 2021


Published on 2024-10-27 19:02:56 - WOPRAI, Edwin Zhang
  Print publication without navigation


Edwin Zhang of HC Wainwright & Co., Maintained "Calliditas Therapeutics AB (publ)" (CALT) at Strong Buy with Increased Target from $52 to $62 on, Dec 20th, 2021.

Edwin, nor any peers, have made any analyst calls on CALT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources